StemCell Institute, Apr-Jun (1Q) Ordinary Profit Decreases by 46%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Aug 7, 2025 3:30 pm JST Earnings

7096 StemCell Institute 【J-GAAP】

Earnings Report

StemCell Institute <7096> [TSE Growth] announced its financial results after the market closed on August 7th (15:30). The ordinary profit (non-consolidated) for the first quarter of the fiscal year ending March 2026 (April to June) dropped 46.0% from the same period last year to 67 million yen. Progress toward the full-year plan of 450 million yen was 14.9%, also falling below the five-year average of 24.0%.

In the most recent three-month period, from April to June (1Q), the operating profit margin significantly dropped from 18.1% in the same period last year to 9.3%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Jun, 2023	577	88	90	75	7.4	41.7	Aug 8, 2023	J-GAAP
Apr - Jun, 2024	678	123	124	178	17.4	47.0	Aug 7, 2024	J-GAAP
Apr - Jun, 2025	700	65	67	43	4.2	ー	Aug 7, 2025	J-GAAP
YoY	+3.2%	-47.2%	-46.0%	-75.8%	-75.6%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024	1,373	258	264	271	26.5	25	Nov 12, 2024	J-GAAP
Apr - Sep, 2025 Guidance	ー	ー	ー	ー	－	0	May 13, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2024	2,481	413	417	310	30.4	0	May 14, 2024	J-GAAP
Mar, 2025	2,679	418	428	385	37.7	25	May 13, 2025	J-GAAP
Mar, 2026 Guidance	3,000	450	450	320	31.8	0	May 13, 2025	J-GAAP
YoY	+12.0%	+7.7%	+5.1%	-16.9%	-15.6%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Apr - Jun, 2024	678	123	124	178	17.4	18.1	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	695	135	140	93	9.1	19.4	Nov 12, 2024	J-GAAP
Oct - Dec, 2024	667	100	103	68	6.7	15.0	Feb 13, 2025	J-GAAP
Jan - Mar, 2025	639	60	61	46	4.5	9.4	May 13, 2025	J-GAAP
Apr - Jun, 2025	700	65	67	43	4.2	9.3	Aug 7, 2025	J-GAAP
YoY	+3.2%	-47.2%	-46.0%	-75.8%	-75.6%